insider24.ch
Company / strategic investorRegistered location :Basel

Varuma AGDeclared Swiss shareholdings

Varuma AG: 3 Swiss companies with a declared holding, including Santhera Pharmaceuticals Holding AG, Basilea Pharmaceutica AG, Allschwil, Addex Therapeutics Ltd. Latest filing: 13.08.2008.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
3
Largest position
4,74 %
Santhera Pharmaceuticals Holding AG
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
13.08.2008
Active since 2004

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held

Santhera Pharmaceuticals Holding AG

4,74 %18.01.2008

Basilea Pharmaceutica AG, Allschwil

4,44 %21.01.2008

Addex Therapeutics Ltd

3,95 %13.08.2008
How to read these figures?

Rates come from the 17 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure5 controlled by · 2 controls

Controlled by

Group entities that file jointly with this shareholder as its head.

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 6

90 days · Downward crossings

0

visible history: 0

First disclosure: 10.12.2004Last disclosure: 13.08.2008

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
8

Latest shareholding disclosures

Below thresholdShareholdings

Spexis Ltd

Varuma AG · Single shareholder

3%Below threshold06.01.2022
PurchaseShareholdings

Spexis Ltd

Varuma AG · Single shareholder

8.57%Voting rights acquired18.05.2019
Below thresholdShareholdings

Spexis Ltd

Varuma AG · Group of shareholders

3%Below threshold18.05.2019
Show 14 older disclosures
PurchaseShareholdings

Spexis Ltd

Varuma AG · Group of shareholders

63.2%Voting rights acquired19.05.2018
Below thresholdShareholdings

Santhera Pharmaceuticals Holding AG

Varuma AG · Group of shareholders

3%Below threshold12.06.2014
PurchaseShareholdings

Addex Therapeutics Ltd

Varuma AG · Single shareholder

1.74%Voting rights acquired28.02.2014
PurchaseShareholdings

Addex Therapeutics Ltd

Varuma AG · Single shareholder

4.06%Voting rights acquired15.08.2013
Below thresholdShareholdings

Basilea Pharmaceutica AG, Allschwil

Varuma AG · Single shareholder

3%Below threshold10.10.2012
PurchaseShareholdings

Addex Therapeutics Ltd

Varuma AG · Single shareholder

2.95%Voting rights acquired25.03.2011
PurchaseShareholdings

Addex Therapeutics Ltd

Varuma AG · Group of shareholders

3.95%Voting rights acquired13.08.2008
PurchaseShareholdings

Basilea Pharmaceutica AG, Allschwil

Varuma AG · Group of shareholders

4.44%Voting rights acquired21.01.2008
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Varuma AG · Group of shareholders

4.74%Voting rights acquired18.01.2008
Below thresholdShareholdings

Santhera Pharmaceuticals Holding AG

Varuma AG · Group of shareholders

5%Below threshold16.11.2007
Below thresholdShareholdings

Basilea Pharmaceutica AG, Allschwil

Varuma AG · Group of shareholders

5%Below threshold30.03.2007
PurchaseShareholdings

Basilea Pharmaceutica AG, Allschwil

Varuma AG · Group of shareholders

5.07%Voting rights acquired08.03.2007
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Varuma AG · Group of shareholders

61.68%Voting rights acquired02.11.2006
PurchaseShareholdings

Basilea Pharmaceutica AG, Allschwil

Varuma AG · Group of shareholders

72.02%Voting rights acquired10.12.2004

insider24.ch

Follow Varuma AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Varuma AG’s disclosed portfolio?

    Santhera Pharmaceuticals Holding AG, Basilea Pharmaceutica AG, Allschwil, Addex Therapeutics Ltd.

    What is Varuma AG’s latest disclosure?

    The latest available disclosure was published on 06.01.2022 and concerns Spexis Ltd. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.